ENROXAN-50
Antibiotic injectable solution
Composition
100 ml of preparation contains active substance Enrofloxacin – 5.0 g; Additional ingredients.
Pharmacologicalproperties
Enrofloxacin is a chemotherapeuti preparati belonging to the group of fluoroquinolones (derivative quinolone-carboxylic acid) of 2nd generati Enrofloxacin inhibits the synthesis of DNA in the nuclei of cells of microorganisms, has bactericidal acti against Gram-positi e and Gram- negative organisms (Staphylococcus aureus, Enterococcus spp., Pasteurella spp., Haemophilus spp., Acti spp., Brucella spp., Bordetella spp., Pseudomonas aeruginosa, Salmonella spp., etc.), and is also acti e against mycoplasmas (Mycoplasma spp.) and chlamydia (Chlamydia spp.).
Administration
Treatment of catt sheep, goats, pigs, dogs, cats and rabbits with respiratory and digesti e tract diseases, caused by microorganisms suscepti to Enrofloxacin.
Routesof administration and dosages
Animal species | Dosage | Durationof treatment | Route of administration |
Cattle, sheep, goats | 0.5 ml per 10 kg body weight | Once daily for 3-5 days | Subcutaneously |
Swine | Intramuscularly | ||
Dogs, cats | 0.1 ml per 1 kg body weight | ||
Rabbits | 0.2-0.4 ml per 1 kg body weight |
Withdrawalperiod
Meat – in 7 days after the last treatment. Milk for human consumpti is allowed in 4 days after the last treatment. Meat and milk received before this ti should be disposed or fed to non-producti e animals, depending on conclusion of veterinarian.
Self life
24 months. After first opening – 14 days if kept in dark place at +5 to +25° С.
Storageconditions
Store in dry, dark places, out of the reach of children, at +5 to +25° С.